Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001654954-19-014167
Filing Date
2019-12-23
Accepted
2019-12-23 07:39:39
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 v122319_424b5.htm 424B5 15517
2 IMAGE tglogo.jpg GRAPHIC 6354
  Complete submission text file 0001654954-19-014167.txt   25681
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

EIN.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-233636 | Film No.: 191303441
SIC: 2834 Pharmaceutical Preparations